Certain Stock Options of CymaBay Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 17-JAN-2022. These Stock Options will be under lockup for 61 days starting from 17-NOV-2021 to 17-JAN-2022.

Details:
Directors and executive officers have agreed, not to offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of, or announce the intention to otherwise dispose of, any shares of common stock (including, without limitation, common stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations promulgated under the Securities Act or securities convertible into or exercisable or exchangeable for common stock),enter into any swap, hedge or similar agreement or arrangement that transfers in whole or in part, the economic risk of ownership of the common stock or securities convertible into or exercisable or exchangeable for common stock, subject to certain exceptions, that, without the prior written consent of Piper Sandler & Co. on behalf of the underwriters, during the period ending 60 days after the date of this prospectus supplement.